Author

E. Pozzo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Cortes-Calabuig· 1 shared B. W. Simons· 1 shared C. Coarfa· 1 shared D. Torella· 1 shared F. Aliberti· 1 shared F. Marino· 1 shared G. Bultynck· 1 shared J. T. Yustein· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Cortes-Calabuig

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Long-Term Culture of Patient-Derived Cardiac Organoids Recapitulated Duchenne Muscular Dystrophy Cardiomyopathy and Disease Progression

V. Marini, F. Marino, F. Aliberti, N. Giarratana, E. Pozzo, R. Duelen, A. Cortes-Calabuig, R. Larovere, T. Vervliet, D. Torella, G. Bultynck, M. Sampaolesi, Y. C. Chai

This study cultured patient-derived cardiac organoids to model Duchenne Muscular Dystrophy cardiomyopathy and disease progression over 93 days.

bioRxiv · Feb 25, 2022Cell Biology

MyoD-Cre driven alterations in K-Ras and p53 lead to a mouse model with histological and molecular characteristics of human rhabdomyosarcoma with direct translational applications

K. Nakahata, B. W. Simons, E. Pozzo, R. Shuck, L. Kurenbekova, C. Coarfa, T. D. Patel, J. T. Yustein

This paper develops a genetically engineered mouse model of rhabdomyosarcoma with molecular features similar to human RMS, providing pre-clinical tools for therapy evaluation.

bioRxiv · Jun 15, 2021 · PreprintCancer Biology